Volume 28, Number 11—November 2022
Research Letter
SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
Table
Primary infection, 102 TCID50 | Secondary infection, 104 TCID50 | Serum neutralizing antibodies (GMT) against indicated virus after primary and secondary infection |
||||
---|---|---|---|---|---|---|
BA.1 | BA.2† | BA.5† | Ancestral | Delta | ||
BA.1 | BA.1 | 83/62 | 10/10 | 10/10 | 7‡/7‡ | 7‡/8‡ |
Ancestral | BA.1 | 34‡/27‡ | 10/10 | 10/10 | 709/1,338 | 90‡/>440‡ |
Delta | BA.1 | 16/60 | 10/35 | 10/53 | 55‡/124‡ | 129/>453 |
*Bold indicates homologous titers. GMT, geometric mean titer; TCID50, 50% tissue culture infectious dose. †Lower limit of detection in indicated assays is 10. In other assays, the lower limit of detection is 5. ‡Serum samples from different sets of 5 mice from the group were tested on days 27 and 56.
Page created: September 09, 2022
Page updated: October 24, 2022
Page reviewed: October 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.